Postmarketing study commitments are becoming routine in the US, Europe and Japan

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1214, 2008-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular Safety and Overall Tolerability of Solifenacin in Routine Clinical Use: A 12-Week, Open-Label, Post-Marketing Surveillance Study

By Michel Martin C.

Drug Safety, Vol. 31, Iss. 6, 2008-01 ,pp. : 505-514

Adis International

Access to resources Recommend Favorite

Safety of Gadoterate Meglumine (Gd-DOTA) as a Contrast Agent for Magnetic Resonance Imaging: Results of a Post-Marketing Surveillance Study in Japan

By Ishiguchi Tsuneo

Drugs in R&D, Vol. 10, Iss. 3, 2010-09 ,pp. : 133-145

Adis International

Access to resources Recommend Favorite

Assessment of Postmarketing Safety-Related Regulatory Actions in Japan

By Ogami Tetsuro Imaizumi Takayuki

Pharmaceutical Medicine, Vol. 26, Iss. 6, 2012-12 ,pp. : 395-403

Adis International

Access to resources Recommend Favorite

Postmarketing study supports rosuvastatin safety

Reactions Weekly, Vol. 1, Iss. 1140, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

US FDA addresses postmarketing drug surveillance concerns

Reactions Weekly, Vol. 1, Iss. 1030, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite